Rapid Capsular Antigen Immunoassay for Diagnosis of Inhalational Anthrax: Preclinical Studies and Evaluation in a Nonhuman Primate Model is a research paper published in mBio (2022). On theSindex it has a DataRank of 0.224. It has been cited 2 times, with 2 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0.0590
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 2 citers.
HHS | National Institutes of Health
Grant: AI059348
HHS | National Institutes of Health
Grant: AI061200
HHS | National Institutes of Health
Grant: AI093365
U.S. Department of Homeland Security
Grant: HSHQDC-15-C-B0067
HHS | National Institutes of Health
Grant: HHSN272201000003I
National Institutes of Health
Grant: 5R01AI093365-05
Immunoassay for capsular antigen for rapid diagnosis of anthrax
National Institutes of Health
Grant: 1R01AI059348-01
B. anthracis:passive immunization with anticapsular mAb
National Institutes of Health
Grant: 5U01AI061200-03
PGA antigenemia for early diagnosis of anthrax
Fields of Study
Keywords
Sustainable Development Goals